AIDS 2022

Risk for STI Doubled Among At-Risk, HIV-Positive MSM Who Experience Stigma

When faced with stigma from the general community, MSM have a twofold increased risk for being diagnosed with an ...

AUGUST 3, 2022

Fostemsavir Data Looking Bright for Heavily Treatment-Experienced Adults With MDR HIV

After 240 weeks, fostemsavir helped HTE adults with MDR HIV-1 infection achieve durable virologic responses, ...

AUGUST 3, 2022

Program Improves Care for Transgender People in Thailand

Combining transgender-specific health services with HIV care appears to be an effective model for engaging and ...

AUGUST 2, 2022

Bringing Equity to PrEP Use in the United States

Programs that promote and distribute PrEP for HIV should be based on equity, rather than equality, according to ...

AUGUST 1, 2022

CAB-LA Effective for PrEP in Sub-Sahara African Women

Long-acting cabotegravir continued to demonstrate superior efficacy in preventing new HIV infections among women in ...

AUGUST 1, 2022

Biktarvy Shows Durable Viral Suppression After 5 Years

Five-year cumulative data from two trials of Biktarvy demonstrated high rates of viral suppression that were ...

AUGUST 1, 2022

New Global Coalition Plans to Accelerate Access to Longer-Acting HIV PrEP

A new coalition co-convened by Unitaid, WHO, the Joint United Nations Programme on HIV/AIDs and the Global Fund is ...

JULY 31, 2022

Progress in HIV Slowed During Pandemic, But Leaders Working to Regain It

There is no doubt the strides made in controlling the HIV pandemic lost ground because of COVID-19, leaders said at ...

JULY 30, 2022

TAF- or TDF-Backbone? Both Appear Efficacious for HIV/HBV Co-Infection

A regimen for treating people with HIV and HBC coinfection with a TAF backbone has similar efficacy with one that ...

JULY 29, 2022

Doxycycline Shows Promise for STI Prevention

Doxycycline administered within 72 hours of sexual activity without a condom significantly reduced rates of ...

JULY 28, 2022

Many Differences in Latest HIV Patient to Achieve HIV Remission With HSCT

A 66-year-old patient living with HIV and acute myeloid leukemia achieved complete remission from both his HIV and ...

JULY 27, 2022

Load more